Nippon Kodoshi Corporation (TYO:3891)

CTI BioPharma Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 13, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	22,049	18,330	19,702	21,221	23,955	33,453
Market Cap Growth	-25.78%	-6.96%	-7.16%	-11.42%	-28.39%	245.94%
Enterprise Value	26,798	25,501	23,842	22,912	22,841	34,139
Last Close Price	2093.00	1740.00	1795.18	1859.39	2047.98	2828.42
PE Ratio	12.90	10.29	13.32	8.60	8.21	16.68
Forward PE	9.97	8.98	11.26	8.08	9.44	17.27
PS Ratio	1.31	1.14	1.33	1.21	1.33	2.10
PB Ratio	0.92	0.77	0.88	0.98	1.24	2.02
P/TBV Ratio	0.92	0.77	0.88	0.99	1.25	2.02
P/FCF Ratio	-	-	-	-	22.08	14.33
P/OCF Ratio	-	4.82	10.32	30.98	8.24	10.39
PEG Ratio	-	0.69	0.69	0.69	0.69	0.69
EV/Sales Ratio	1.60	1.59	1.61	1.30	1.26	2.15
EV/EBITDA Ratio	7.71	7.31	7.58	4.84	4.21	8.45
EV/EBIT Ratio	10.54	10.37	13.86	6.89	5.62	12.36
EV/FCF Ratio	-	-	-	-	21.05	14.63
Debt / Equity Ratio	0.38	0.35	0.37	0.27	0.15	0.23
Debt / EBITDA Ratio	2.61	2.37	2.60	1.21	0.53	0.94
Debt / FCF Ratio	-	-	-	-	2.63	1.64
Asset Turnover	0.47	0.46	0.46	0.62	0.71	0.67
Inventory Turnover	1.52	1.42	1.35	1.72	2.20	2.17
Quick Ratio	1.59	1.34	1.66	1.87	1.87	1.88
Current Ratio	2.89	2.59	3.28	3.87	3.14	2.92
Return on Equity (ROE)	7.34%	7.70%	6.73%	12.07%	16.24%	12.81%
Return on Assets (ROA)	4.48%	4.44%	3.33%	7.32%	9.93%	7.29%
Return on Capital (ROIC)	4.79%	4.90%	3.72%	8.40%	11.93%	9.04%
Return on Capital Employed (ROCE)	8.70%	8.60%	6.00%	12.70%	19.10%	13.80%
Earnings Yield	7.81%	9.72%	7.51%	11.63%	12.18%	6.00%
FCF Yield	-	-11.69%	-7.49%	-13.47%	4.53%	6.98%
Dividend Yield	3.33%	3.45%	2.79%	2.69%	1.17%	0.78%
Payout Ratio	-	29.82%	43.41%	13.09%	9.94%	10.72%
Buyback Yield / Dilution	0.25%	0.15%	1.15%	-0.08%	-0.03%	0.00%
Total Shareholder Return	3.59%	3.60%	3.94%	2.61%	1.14%	0.78%

Updated Jan 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.